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Abstract 
Introduction: Solitary fibrous tumor is associated with serosal surfaces.  Location in the salivary glands is extremely 
unusual. Extrathoracic tumors have an excellent prognosis associated with their benign clinical behavior. We report 
an aggressive and recurrent case of this tumor. We review the clinical presentation, inmunohistochemical profiles 
and therapeutic approaches.
Case Report: A 73-years-old woman presented a mass in her right parotid gland. She had a past history of right 
superficial parotidectomy due to a neurilemoma. FNAB and magnetic resonance were non-specific. After a tumor 
resection, microscopic findings were spindled tumor cells with reactivity to CD34, bcl-2 and CD99 and the tumor 
was diagnosed as Solitary Fibrous Tumor. The patient suffered two recurrences and the tumor had a histological 
aggressive behavior and a destruction of the cortical bone of the mandible adjacent to the mass. A marginal mandi-
bulectomy with an alveolar inferior nerve lateralization was performed. 
Conclusions: Solitary fibrous tumor is a very rare tumor. Usually, they are benign, but occasionally they can be 
aggressive. Complete resection is the most important prognostic factor and no evidence supports the efficacy of any 
therapy different to surgery. Due to the unknown prognosis and to the small number of cases reported, a long-term 
follow-up is guaranteed.
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Introduction
Solitary fibrous tumor was first described in the pleura 
by Lietaud in 1767, followed by Wagner in 1870. Klem-
perer and Rabin, in 1931, classified pleural tumors into 
two types: diffuse mesotheliomas and localized meso-
theliomas or solitary fibrous tumor [SFT].
SFT is one generally associated with serosal surfaces, 
but in recent years it has been reported in extrapleural 
sites such as the liver, adrenal gland, skin, and less com-
monly in the head and neck, accounting for around 6% 
of the cases (1).  In 1991, Witkin and Rosai (2) were the 
first to report a case in the head and neck region. A SFT 
located within the salivary glands is very unusual and 
with few cases described in the literature (3-9).
These tumors tend to present as a well defined, palpable 
and slowly growing masses. Clinical presentation and 
radiographic findings are similar to that of other tumors 
which are more common in salivary glands.
Extrathoracic SFT has an excellent prognosis associated 
with their benign clinical behavior. We report an atypi-
cal and recurrent case of SFT with aggressive behavior. 
This article reviews the clinical presentation, histologic 
features, inmunohistochemical profiles and therapeutic 
approaches of SFT of the parotid gland in the context of 
a case report.
Case Report
A 73-year-old woman presented with a several months 
history of a mass in the right parotid gland region. She 
had a past medical history of right superficial paroti-
dectomy due to the presence of a neurilemoma [cellular 
schwannoma] which had been treated 17 years previ-
ously in another medical center. She had hypertension 
and hypertriglyceridemia, but no toxic habits.
She presented with a 2 cm palpable, firm, mobile, pain-
less and slowly growing mass in her right parotid gland. 
There was no facial paralysis or constitutional symptoms 
and no palpable nodes on neck examination. FNAB was 
unspecific. Magnetic resonance imaging revealed a 
well-defined tumor measuring 2 cm in its greatest di-
mension, in the supposed location of the superficial lobe 
of the right parotid gland. It showed high signal intensity 
with homogeneous enhancement in T2-weighted images 
(Fig. 1). The principal suspicion was a recurrence of pa-
rotid schwannoma.
The patient underwent a tumor resection. The specimen 
was well-defined and not encapsulated, measuring 2 x 
2 cm with a white surface. Microscopic findings were 
that of tumor cells arranged in a storiform pattern with 
numerous ramifying vessels and hyalinized walls (Fig. 
1). The tumor cells were round to spindled, with taper-
ing cytoplasm.  These cells exhibited a characteristic 
inmunophenotype. They showed reactivity to CD34, 
bcl-2 (Fig. 1) and CD99, but not to AE/1, AE/2, EMA, or 
S-100. The tumor exhibited a Ki67 index of 5%. Based 
on these findings, the tumor was diagnosed as SFT.
Two years later, the patient suffered a recurrence. She 
developed a mass measuring 6 cm localized under the 
masseter muscle. During the excision of the tumor, de-
struction of the adjacent mandibular cortical bone was 
observed. The margin of the tumoral resection in this 
location was microscopically positive.
A new magnetic resonance imaging and a computed to-
mography were carried out (Fig. 2). An heterogeneous 
image within the masseter muscle was observed which 
was compatible with possible tumoral remains. There 
was an osteolytic lesion in the ramus of the mandible 
suggestive of invasion of the mandibular nerve foramen 
(Fig. 2).
Fig. 1. A. Contrast-enhanced T2-weighted magnetic reso-
nance image.  Note a well-defined tumor in the right parotid 
gland. It shows high signal intensity with homogeneous en-
hancement; B. Tumor cells arranged in a storiform pattern. C. 
They show reactivity with bcl-2.
Fig. 2. A. 3D CT image showing osteolytic lesion; B. Intraoperative 
view showing destruction of the buccal cortical bone of the mandible 
produced by the tumor.
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In this context, a marginal mandibulectomy with an al-
veolar inferior nerve lateralization was performed (Fig. 
3). We confirmed negative margins of the resection in 
the bone, the nerve and the residual masseter muscle. We 
used bone grafts from the mandibular angle and a recon-
struction plate to provide better stability (Fig. 3).
have been described in the literature. There is no pre-
dilection based on age or gender. Bauer et al. (10) pre-
sented a review of the literature extending from 1960 
to 2011, finding only 22 reported cases in the parotid 
region, 3 of which were malignant.
These tumors usually present as a well defined, palpa-
ble, painless and slowly growing mass. Occasionally, 
they can produce compression symptoms which should 
prompt suspicion of extension to the parapharyngeal 
space (3).  Clinical presentation is similar to that of other 
tumors such as pleomorphic adenomas, schwannomas, 
fibrous histiocytomas and lipomas. Radiographic find-
ings are nonspecific. Magnetic resonance imaging usual-
ly shows an isointense mass on T1-weighted images and 
high signal intensity with enhancement in T2-weighted 
images (8), as was found in the case we present.
Therefore, a diagnosis of SFT can only be performed 
based on histological and immunohistochemical find-
ings. The macroscopic examination of the tumor shows 
a well-defined and encapsulated mass which may be ac-
companied by bone destruction, though it is normally 
free of infiltration. The presence of bone destruction 
should prompt a suspicion of malignancy, though this 
finding is not an indispensable requisite as a malignant 
tumor can have no bone erosion. Bone destruction can 
be attributed to a long-standing pressure effect (11). 
In addition to infiltration and disease recurrence, other 
features of histological malignancy such as a high mi-
totic rate, high cellularity, pleomorphism, necrosis and 
hemorrhages should be assessed. In the present case, 
necrosis and hemorrhages were absent, but mitotic rate 
and Ki67 index were increased. These histological find-
ings correlated with an aggressive clinical behavior with 
bone destruction and disease recurrence.
Microscopic findings of SFT include tumor cells ar-
ranged in a storiform pattern with numerous ramifying 
vessels and hyalinized walls. There are alternating zones 
of hypercellularity and hypocellularity in fibrous areas. 
Tumor cells are round to spindled with tapering cyto-
plasm. Histologically, a diagnosis of SFT is also diffi-
cult because there are many tumors that display similar 
findings.
For this reason, immunohistochemical examinations are 
required in order to make a differential diagnosis. SFT 
shows reactivity to CD34, bcl-2, vimentin and CD99, 
but is negative to keratin, EMA, S-100, desmin, smooth 
muscle actin and muscle-specific actin. The presence of 
EMA, any keratin or S-100 protein will rule out many 
common salivary gland tumors such as pleomorphic ad-
enoma. CD34 is a hematopoietic progenitor cell antigen 
that is strongly positive in most cases of SFT, though it 
may not be positive in all cases (12). CD34 tends to re-
duce reactivity in malignant SFT when compared to be-
nign tumors (13). Peripheral neural sheath tumors such 
as schwannomas are positive to CD34 in some cases, but 
The clinical aggressiveness of bone destruction cor-
related histologically with an increased in Ki67 index 
[15%] and mitotic rate. Microscopically, bone remodel-
ling without infiltration was observed. The patient has 
remained free of disease for 9 months postoperatively.
Discussion
SFT is an uncommon benign lesion of mesenchymal 
origin. The finding of SFT in the head and neck is rare. 
Moreover, very few cases affecting the partotid gland 
Fig. 3. Intraoperative views. A. Mandibulectomy with 
an alveolar inferior nerve lateralization; B. Bone grafts 
from mandibular angle and a reconstruction plate for 
reconstructing the defect.
e302
J Clin Exp Dent. 2014;6(3):e299-302. Parotid gland solitary fibrous tumor
are strongly reactive to S-100 protein. Schwannoma con-
tain Antoni A and B areas which are absent in SFT. This 
was essential in arriving at a differential diagnosis in the 
case we present. Dermatofibrosarcoma protuberans can 
display CD34 reactivity but the pattern of growth and 
collagen deposition is different and shows more mitotic 
activity. There is a clinical, radiographic and immuno-
histochemical overlap between SFT and hemangioperi-
cytoma. Currently, this tumor is considered a subtype of 
SFT.  A spindle cell lipoma with a prominent spindle cell 
component is very difficult to distinguish. The majority 
of carcinomas, melanomas and lymphomas are negative 
for CD34.
Complete local surgical excision with negative micro-
scopic margins is the single most important prognostic 
factor in SFT. Some authors have documented disease 
recurrence at other extrapleural sites decades after the 
primary tumor was first identified (1) and for this reason 
close long-term follow up is recommended. Surgery is 
recognized as the treatment of choice but adjuvant treat-
ments such as radiotherapy or chemotherapy have also 
been advocated. To this date, the available literature only 
describes three cases of SFT that have been considered 
as malignant.  Suarez Roa et al. (14) report a case in 
the parotid region with no anomalies at glandular level. 
They considered it to be a low-grade malignancy and 
treated it with surgery and radiotherapy.  A year later, 
there was no sign of disease recurrence.  Yang et al. (15) 
also added radiotherapy as a complementary treatment 
in a case of histologically malignant parotid region SFT. 
Messa-Botero et al. (7) present the first documented 
case of parotid SFT with distant metastases.  In this lat-
ter case, resection of the primary tumor was the sole 
treatment administered.
Ganly et al. (11) suggest that patients with positive sur-
gical margins or whose tumors have a malignant compo-
nent benefit from adjuvant postoperative radiotherapy. 
However, there are few reports concerning this issue and 
their follow up periods are of short duration.
In the case we presented, there were both clinical and 
histological indications of aggressiveness.  However, in 
the end we were able to successfully achieve negative 
microscopic surgical margins. We presented the case to 
the Head and Neck Oncology Committee and decided 
that no adjuvant therapy was necessary.
The prognosis of this tumor is generally unknown. Most 
extrathoracic SFT have an excellent prognosis, but some 
authors have reported cases with aggressive behaviour 
and multiple recurrences, invasion of local tissues, as 
well the presence of distant metastases (7,14).
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